CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 900 of 1294 entries

View as:

A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT01590836 Org: User:

Start: 04/30/12 End: 06/30/12 Due: 06/30/13

Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction

Phase: N/A Priority: Normal

NCT ID: NCT01492218 Org: User:

Start: 03/15/04 End: 08/30/04 Due: 08/30/05

Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics

Phase: N/A Priority: Normal

NCT ID: NCT01002768 Org: User:

Start: 10/31/09 End: 03/31/10 Due: 03/31/11

Surveillance Study of NovoRapid® for New Drug Re-examination

Phase: N/A Priority: Normal

NCT ID: NCT01490112 Org: User:

Start: 01/31/05 End: 06/30/06 Due: 06/30/07

A Research Study Looking Into Blood Levels of NNC0174-0833 in People With Normal and Impaired Kidney Function

Phase: N/A Priority: Normal

NCT ID: NCT04209049 Org: User:

Start: 01/15/20 End: 01/05/21 Due: 01/05/22

Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People

Phase: N/A Priority: Normal

NCT ID: NCT04524832 Org: User:

Start: 09/29/20 End: 02/25/22 Due: 02/25/23

Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function

Phase: N/A Priority: Normal

NCT ID: NCT01508806 Org: User:

Start: 08/31/05 End: 03/31/06 Due: 03/31/07

A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity

Phase: N/A Priority: Normal

NCT ID: NCT05369390 Org: User:

Start: 05/11/22 End: 01/09/24 Due: 01/09/25

Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT01324505 Org: User:

Start: 03/31/11 End: 01/31/12 Due: 01/31/13

A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy

Phase: N/A Priority: Normal

NCT ID: NCT05503927 Org: User:

Start: 01/02/23 End: 08/15/27 Due: 08/15/28

A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate Formulations

Phase: N/A Priority: Normal

NCT ID: NCT05766709 Org: User:

Start: 03/02/23 End: 02/09/24 Due: 02/09/25

A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets

Phase: N/A Priority: Normal

NCT ID: NCT04817644 Org: User:

Start: 09/10/21 End: 07/03/23 Due: 07/03/24

A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are Chinese

Phase: N/A Priority: Normal

NCT ID: NCT04016974 Org: User:

Start: 10/08/19 End: 02/26/21 Due: 02/26/22

Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency

Phase: N/A Priority: Normal

NCT ID: NCT01563926 Org: User:

Start: 10/23/00 End: 10/10/02 Due: 10/10/03

Investigating the Effect of Ryzodeg® in Adult Patients With Type 2 Diabetes in Lebanon

Phase: N/A Priority: Normal

NCT ID: NCT04892069 Org: User:

Start: 05/27/21 End: 11/18/21 Due: 11/18/22

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

Phase: N/A Priority: Normal

NCT ID: NCT05726227 Org: User:

Start: 07/07/23 End: 12/07/26 Due: 12/07/27

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT01076647 Org: User:

Start: 03/31/10 End: 12/31/10 Due: 12/31/11

Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal Women

Phase: N/A Priority: Normal

NCT ID: NCT01705249 Org: User:

Start: 08/14/01 End: 06/06/03 Due: 06/06/04

Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury

Phase: N/A Priority: Normal

NCT ID: NCT00124293 Org: User:

Start: 10/06/04 End: 11/23/05 Due: 11/23/06

A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Malaysia

Phase: N/A Priority: Normal

NCT ID: NCT01934673 Org: User:

Start: 09/30/13 End: 11/30/13 Due: 11/30/14

Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in Germany

Phase: N/A Priority: Normal

NCT ID: NCT00665808 Org: User:

Start: 10/31/07 End: 12/31/08 Due: 12/31/09

Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results

Phase: N/A Priority: Normal

NCT ID: NCT01179048 Org: User:

Start: 08/31/10 End: 12/17/15 Due: 12/17/16

A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets

Phase: N/A Priority: Normal

NCT ID: NCT04097600 Org: User:

Start: 09/30/19 End: 01/20/21 Due: 01/20/22

Research Study to Investigate the Effect of NNC0174-0833 on a Birth Control Pill in Women Who Are Not Able to Become Pregnant

Phase: N/A Priority: Normal

NCT ID: NCT04074174 Org: User:

Start: 09/12/19 End: 03/06/20 Due: 03/06/21

Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

Phase: N/A Priority: Normal

NCT ID: NCT03693430 Org: User:

Start: 10/05/18 End: 03/23/21 Due: 03/23/22

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes	NCT01590836	Novo Nordisk A/S	user2@example.com	None	2012-04-30	2012-06-30	2013-06-30	-	-	2025-07-14
Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction	NCT01492218	Novo Nordisk A/S	user2@example.com	None	2004-03-15	2004-08-30	2005-08-30	-	-	2025-07-14
Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics	NCT01002768	Novo Nordisk A/S	user2@example.com	None	2009-10-31	2010-03-31	2011-03-31	-	-	2025-07-14
Surveillance Study of NovoRapid® for New Drug Re-examination	NCT01490112	Novo Nordisk A/S	user2@example.com	None	2005-01-31	2006-06-30	2007-06-30	-	-	2025-07-14
A Research Study Looking Into Blood Levels of NNC0174-0833 in People With Normal and Impaired Kidney Function	NCT04209049	Novo Nordisk A/S	user2@example.com	None	2020-01-15	2021-01-05	2022-01-05	-	-	2025-07-14
Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People	NCT04524832	Novo Nordisk A/S	user2@example.com	None	2020-09-29	2022-02-25	2023-02-25	-	-	2025-07-14
Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function	NCT01508806	Novo Nordisk A/S	user2@example.com	None	2005-08-31	2006-03-31	2007-03-31	-	-	2025-07-14
A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity	NCT05369390	Novo Nordisk A/S	user2@example.com	None	2022-05-11	2024-01-09	2025-01-09	-	-	2025-07-14
Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes	NCT01324505	Novo Nordisk A/S	user2@example.com	None	2011-03-31	2012-01-31	2013-01-31	-	-	2025-07-14
A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy	NCT05503927	Novo Nordisk A/S	user2@example.com	None	2023-01-02	2027-08-15	2028-08-15	-	-	2025-07-14
A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate Formulations	NCT05766709	Novo Nordisk A/S	user2@example.com	None	2023-03-02	2024-02-09	2025-02-09	-	-	2025-07-14
A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets	NCT04817644	Novo Nordisk A/S	user2@example.com	None	2021-09-10	2023-07-03	2024-07-03	-	-	2025-07-14
A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are Chinese	NCT04016974	Novo Nordisk A/S	user2@example.com	None	2019-10-08	2021-02-26	2022-02-26	-	-	2025-07-14
Evaluating Acceptance of New Liquid Somatropin Formulation in Children With Growth Hormone Deficiency	NCT01563926	Novo Nordisk A/S	user2@example.com	None	2000-10-23	2002-10-10	2003-10-10	-	-	2025-07-14
Investigating the Effect of Ryzodeg® in Adult Patients With Type 2 Diabetes in Lebanon	NCT04892069	Novo Nordisk A/S	user2@example.com	None	2021-05-27	2021-11-18	2022-11-18	-	-	2025-07-14
A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight	NCT05726227	Novo Nordisk A/S	user2@example.com	None	2023-07-07	2026-12-07	2027-12-07	-	-	2025-07-14
Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes	NCT01076647	Novo Nordisk A/S	user2@example.com	None	2010-03-31	2010-12-31	2011-12-31	-	-	2025-07-14
Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal Women	NCT01705249	Novo Nordisk A/S	user2@example.com	None	2001-08-14	2003-06-06	2004-06-06	-	-	2025-07-14
Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury	NCT00124293	Novo Nordisk A/S	user2@example.com	None	2004-10-06	2005-11-23	2006-11-23	-	-	2025-07-14
A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Malaysia	NCT01934673	Novo Nordisk A/S	user2@example.com	None	2013-09-30	2013-11-30	2014-11-30	-	-	2025-07-14
Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in Germany	NCT00665808	Novo Nordisk A/S	user2@example.com	None	2007-10-31	2008-12-31	2009-12-31	-	-	2025-07-14
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results	NCT01179048	Novo Nordisk A/S	user2@example.com	None	2010-08-31	2015-12-17	2016-12-17	-	-	2025-07-14
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets	NCT04097600	Novo Nordisk A/S	user2@example.com	None	2019-09-30	2021-01-20	2022-01-20	-	-	2025-07-14
Research Study to Investigate the Effect of NNC0174-0833 on a Birth Control Pill in Women Who Are Not Able to Become Pregnant	NCT04074174	Novo Nordisk A/S	user2@example.com	None	2019-09-12	2020-03-06	2021-03-06	-	-	2025-07-14
Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity	NCT03693430	Novo Nordisk A/S	user2@example.com	None	2018-10-05	2021-03-23	2022-03-23	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance